The Immune Response Modifier Resiquimod Mimics CD40-Induced B Cell Activation
- 1 February 2001
- journal article
- Published by Elsevier in Cellular Immunology
- Vol. 208 (1), 9-17
- https://doi.org/10.1006/cimm.2001.1769
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Adjuvant Activities of Immune Response Modifier R-848: Comparison with CpG ODNCellular Immunology, 2000
- Membrane-bound CD154, but not CD40-specific antibody, mediates NF-κB-independent IL-6 production in B cellsEuropean Journal of Immunology, 1999
- CpG‐containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: A new class of vaccine adjuvantsEuropean Journal of Immunology, 1997
- Immune Activation by Bacterial DNA: A New Genetic CodeImmunity, 1996
- Functions of CD40 and Its Ligand, gp39 (CD40L)Critical Reviews in Immunology, 1996
- Immunomodulating and antiviral activities of the imidazoquinoline S-28463Antiviral Research, 1995
- Signaling via major histocompatibility complex class II molecules and antigen receptors enhances the B cell response to gp39/CD40 ligandEuropean Journal of Immunology, 1995
- Costimulation of T cells for tumor immunityImmunology Today, 1993
- CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B-cell activationImmunology Today, 1992
- Phosphatidyl choline is recognized by a series of Ly-1+ murine B cell lymphomas specific for erythrocyte membranes.The Journal of Experimental Medicine, 1986